A J Muñoz Martín

PhD in Medicine from the Complutense University of Madrid. He works in the Digestive Cancer Unit of the Oncology Service of the Gregorio Marañón Hospital in Madrid. He combines their clinical job taking care of patients, with the research projects in Oncology. Vice President of the Ethics and Clinical Research Committee of the Hospital. Coordinator of the working group Cancer and Thrombosis of the Spanish Society of Medical Oncology (SEOM). He has leaded several Research studies on different types of tumors, estimating the incidence and risk of associated thrombosis. PI of international clinical studies, among which SAVE ONCO and CARAVAGGIO stand out. In the area of cancer genomics are relevants their studies of oncogenic molecular alterations associated with thromboenbolic risk: ALK and ROS-1 realignment in non-small cell lung cancer and b-raf mutations in colorectal cancer. He currently lead a project on the risk of thrombosis in locally advanced and metastatic pancreatic cancer related with treatment with systemic chemotherapy in an outpatient setting, using liquid biopsy techniques.